MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 42 filers reported holding MYOVANT SCIENCES LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,879 | -99.8% | 403,529 | +2.0% | 0.00% | +100.0% |
| Q3 2022 | $7,102,000 | +36.5% | 395,456 | -5.5% | 0.00% | 0.0% |
| Q2 2022 | $5,202,000 | -0.3% | 418,520 | +6.8% | 0.00% | 0.0% |
| Q1 2022 | $5,219,000 | -9.5% | 391,834 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $5,770,000 | -28.9% | 370,606 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $8,118,000 | +3.4% | 361,806 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $7,851,000 | +14.7% | 344,823 | +3.6% | 0.00% | 0.0% |
| Q1 2021 | $6,847,000 | +3040.8% | 332,719 | +1684.5% | 0.00% | – |
| Q1 2017 | $218,000 | +7.4% | 18,645 | +14.0% | 0.00% | – |
| Q4 2016 | $203,000 | – | 16,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 65,000 | $808,000 | 1.13% |
| Bellevue Group AG | 5,919,639 | $73,581,000 | 1.04% |
| Rhenman & Partners Asset Management AB | 310,000 | $3,853,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 279,335 | $3,472,000 | 0.22% |
| TORRAY INVESTMENT PARTNERS LLC | 81,621 | $1,015,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 302,120 | $3,755,000 | 0.14% |
| Virtus ETF Advisers LLC | 22,356 | $278,000 | 0.10% |
| Tarbox Family Office, Inc. | 27,500 | $342,000 | 0.08% |
| BOURGEON CAPITAL MANAGEMENT LLC | 15,200 | $189,000 | 0.05% |
| JANUS HENDERSON GROUP PLC | 5,449,107 | $67,735,000 | 0.05% |